Claims for Patent: 9,228,192

Summary for Patent: 9,228,192

Title:	Plant transformation with in vivo assembly of a sequence of interest using a site-specific recombinase
Abstract:	A process of producing transgenic plants or plant cells stably transformed on a chromosome with a DNA sequence of interest capable of expressing a function of interest, said process comprising (a) providing plant cells or plants with at least two different vectors that are adapted to recombine with each other between site-specific recombination sites compatible with a site-specific recombinase that is also provided in order to produce a non-replicating recombination product containing said DNA sequence of interest, (ii) said at least two different vectors are adapted for integrating said DNA sequence of interest into said chromosome, (iii) said DNA sequence of interest contains sequence portions from at least two of said at least two different vectors, said sequence portions being necessary for expressing said function of interest from said DNA sequence of interest; and (b) selecting plants or plant cells expressing said function of interest.
Inventor(s):	Giritch; Anatoly (Halle/Saale, DE), Eliby; Serik (Halle/Saale, DE), Marillonnet; Sylvestre (Halle/Saale, DE), Klimyuk; Victor (Halle/Saale, DE), Gleba; Yuri (Halle/Saale, DE)
Assignee:	BAYER CROPSCIENCE N.V. (Diegem, BE)
Application Number:	10/544,135
Patent Claims:	1. A process of producing transgenic plants or plant cells comprising a chromosome stably transformed with a DNA sequence of interest, said plants or plant cells being capable of expressing a protein of interest from said DNA sequence of interest, said process comprising (a) providing a plant cell with at least two different vectors in one step by Agrobacterium-mediated delivery, whereby (i) said at least two different vectors are adapted to recombine with each other by site-specific recombination in said plant cells between site-specific recombination sites that are present on said at least two different vectors and are compatible with a site-specific recombinase, and wherein step (a) comprises providing said site-specific recombinase by including an expressible sequence coding for said recombinase on a vector of said at least two different vectors, said recombinase being specific for said recombination sites for producing a non-replicating recombination product assembled from said at least two different vectors and containing said DNA sequence of interest, (ii) said at least two different vectors are adapted for integrating said DNA sequence of interest into said chromosome, (iii) said DNA sequence of interest contains sequence portions from said at least two different vectors, said sequence portions being necessary for expressing said protein of interest from said DNA sequence of interest; and (b) selecting plants or plant cells expressing said protein of interest. 2. The process of claim 1, wherein each of said at least two different vectors is provided by a different Agrobacterium cell or strain. 3. The process of claim 1, wherein one or all of said at least two different vectors contain(s) a functional cytokinin autonomy gene whereas said DNA sequence of interest is devoid of a functional cytokinin autonomy gene. 4. The process of claim 1, wherein expressibility of said sequence coding for said recombinase is destroyed by said site-specific recombination. 5. The process of claim 1, wherein said at least two different vectors are adapted such that said DNA sequence of interest has T-DNA border sequences that facilitate integration of said DNA sequence of interest into said chromosome. 6. The process of claim 1, wherein said at least two different vectors are adapted such that said DNA sequence of interest contains homology sequences that facilitate integration of said DNA sequence of interest into said chromosome by homologous recombination. 7. The process of claim 1, wherein said at least two different vectors are adapted for introducing said DNA sequence of interest into said chromosome by site-specific integration. 8. The process of claim 1, wherein step (b) further comprises screening for plants or plant cells having said DNA sequence of interest integrated in said chromosome. 9. The process of claim 1, wherein step (b) further comprises screening for cells or plants in which said site-specific recombination between said at least two vectors has occurred. 10. The process of claim 1, wherein said at least two different vectors are adapted such that said DNA sequence of interest contains a selectable marker gene or a sequence that allows in step (b) screening for transformed plants or plant cells containing said DNA sequence of interest. 11. The process of claim 1, wherein a sequence portion of one of said at least two different vectors contains a selectable marker under translational control of an internal ribosome entry site (IRES) element. 12. The process of claim 11, wherein said selectable marker cannot be transcribed in said plant cells from one of said at least two different vectors but is placed by said site-specific recombination under the control of genetic elements allowing transcription of said selectable marker. 13. The process of claim 1, wherein at least one of said at least two different vectors contain a counter-selectable marker gene or another sequence that allows screening against transformed cells containing said vectors. 14. The process of claim 13, wherein said counter-selectable marker gene or said another sequence that allows screening against transformed cells containing said vectors is under translational control of an internal ribosome entry site (IRES) element. 15. The process of claim 1, wherein said expressing comprises intron-mediated cis-splicing. 16. The process of claim 15, wherein a first vector of said at least two different vectors contains a first sequence portion that contains: a first part of a sequence coding for the protein to be expressed and, downstream thereof, a 5' part of an intron, and a second vector of said at least two different vectors contains a second sequence portion that contains: a second part of a sequence coding for the protein to be expressed and, upstream thereof, a 3' part of an intron. 17. The process of claim 1, wherein three or more different vectors are provided to said plant cell in step (a) and two or more different transgenic plants or plant cells are produced, said different transgenic plants or plant cells having different DNA sequences of interest integrated in a chromosome. 18. The process of claim 1, wherein said plant cells are provided with two different vectors, and said DNA sequence of interest contains a sequence portion from each of these two vectors. 19. The process of claim 1, comprising the following steps (A) and (B): (A) providing plants or plant cells with a mixture of (i) a set of m primary vectors each having a primary sequence portion selected from the set a.sub.1, a.sub.2, . . . , a.sub.m and (ii) a set of n secondary vectors each having a secondary sequence portion selected from the set b.sub.1, b.sub.2, . . . , b.sub.n, whereby m and n are independent of each other and both are integers of >1, said primary vectors and said secondary vectors are adapted such that each member of said set of primary vectors can recombine with every member of said set of n secondary vectors by site-specific recombination for producing recombination products containing different DNA sequences of interest, each DNA sequence of interest comprises a member of said set of primary sequence portions and a member of said set of secondary sequence portions, both said sequence portion members are necessary for expressing said protein of interest from said DNA sequence of interest; and said primary vectors and said secondary vectors are adapted to integrate said DNA sequences of interest into a chromosome; and (B) selecting transformed plants or plant cells expressing said protein of interest from a DNA sequence of interest. 20. The process of claim 1, comprising the following steps (A) and (B): (A) providing plants or plant cells with a mixture of (i) a primary vector having a primary sequence portion a.sub.1 and (ii) a set of n secondary vectors each having a secondary sequence portion selected from the set b.sub.1, b.sub.2, . . . , b.sub.n, whereby n is an integer of >1, said primary sequence portion a.sub.1 is necessary for expressing the function of a secondary sequence portion b.sub.1, b.sub.2, . . . , b.sub.n, said primary vector and said secondary vectors are adapted such that said primary vector can recombine with every member of said set of n secondary vectors by site-specific recombination for producing recombination products containing different DNA sequences of interest of type a.sub.1b.sub.1, a.sub.1b.sub.2, . . . , a.sub.1b.sub.n or type b.sub.1a.sub.1, b.sub.2a.sub.1, . . . , b.sub.na.sub.1, said primary vector and said secondary vectors are adapted to integrate said DNA sequences of type a.sub.1b.sub.1, a.sub.1b.sub.2, . . . , a.sub.1b.sub.n or type b.sub.1a.sub.1, b.sub.2a.sub.1, . . . , b.sub.na.sub.1 into a chromosome; and (B) selecting transformed plants or plant cells expressing a protein of interest from a DNA sequence of interest. 21. The process of claim 19, further comprising determining a phenotypic feature of a transformed plant or plant cell selected in step (B) due to a protein encoded by the primary sequence portion, and/or the secondary sequence portion, and/or a combination of the primary sequence portion and the secondary sequence portion.

Details for Patent 9,228,192

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2023-01-31
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2023-01-31
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2023-01-31